Venaxis, Inc.
(NASDAQ : APPY)

( )
APPY After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
Loading APPY News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
0.15%72.471.2%$698.33m
CELGCelgene Corporation
0.71%117.391.3%$685.14m
AMGNAmgen Inc.
-0.15%145.071.0%$640.82m
BIIBBiogen Inc.
0.25%290.961.2%$543.42m
REGNRegeneron Pharmaceuticals, Inc.
-0.24%368.953.6%$400.43m
ALXNAlexion Pharmaceuticals, Inc.
-0.61%124.171.9%$372.24m
ILMNIllumina, Inc.
-1.19%126.403.0%$184.89m
VRTXVertex Pharmaceuticals Incorporated
3.40%78.122.9%$171.61m
INCYIncyte Corporation
2.34%107.212.4%$169.49m
TSROTESARO, Inc.
0.22%139.8717.1%$164.06m
IONSIonis Pharmaceuticals, Inc.
3.15%47.4510.0%$156.72m
EXELExelixis, Inc.
2.36%18.256.4%$128.45m
BLUEBluebird Bio, Inc.
9.43%78.9523.3%$121.32m
BMRNBioMarin Pharmaceutical Inc.
0.66%82.994.5%$116.36m
AAgilent Technologies, Inc.
0.72%44.851.6%$114.69m

Company Profile

Venaxis, Inc. is a vitro diagnostic company. The company focuses on the commercializing of its blood-based test to serve as an adjunctive test in the diagnosis and treatment of acute appendicitis in children adolescent and young adult patients. Venaxis was founded on July 24, 2000 and is headquartered in Castle Rock, CO.